Gautam Borthakur, Hagop Kantarjian, Keyur P. Patel, Farhad Ravandi, Wei Qiao, Stefan Faderl, Tapan Kadia, Raja Luthra, Sherry Pierce and Jorge E. Cortes Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemia Cancer 118
Version of Record online: 17 MAY 2012 | DOI: 10.1002/cncr.27571
Clinical outcome analysis in patients with normal-karyotype acute myelogenous leukemia and fms-like tyrosine kinase receptor 3 internal tandem duplication mutation may need to take into account mutant burden and the number of internal tandem duplication mutations in addition to the categorical variable of presence or absence of mutation.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field